Tagged With: Opioids
Study: Majority Of Chronic Pain Patients Replace Opioids With Cannabis
More than two-thirds of chronic pain patients registered to legally access medical cannabis products substitute marijuana for prescription opioids, according to data published in The Journal of Headache and Pain. Investigators from the United States and Canada assessed the use of medical cannabis and prescription drugs in a cohort of over 2,000 Canadian patients licensed … Continue reading
When It Comes To The Issue Of Cannabis And Opioids, The DEA Admits It Knows Nothing
In testimony before Congress last week, by DEA acting administrator Robert Patterson opined that the medicalization of cannabis is exacerbating opioid abuse. But when prompted to provide evidence in support of the agency’s position, he acknowledged that he could not. Further, he denied being aware of any evidence — including recent, well-publicized studies by the … Continue reading
New York: Patients Using Fewer Opioids Following Enrollment In Medical Cannabis Program
Patients enrolled in New York state’s medical cannabis program reduce their use of opioids and spend less money on prescription medications, according to data published online in the journal Mental Health Clinician. Investigators from the GPI Clinical Research in Rochester and the University of Buffalo assessed trends in patients’ medical cannabis and prescription drug use … Continue reading
Study: Medical Cannabis Registrants More Likely To Cease Using Opioids Compared To Non-Participants
Chronic pain patients enrolled in a statewide medical cannabis access program are significantly more likely to either reduce or cease their use of opioids as compared to non-enrolled patients suffering from similar pain conditions, according to data published online in the journal PLOS One. A team of investigators at the University of New Mexico assessed … Continue reading
Congressman Earl Blumenauer: Medical Cannabis Is Safer Than Opioids
Congressman Earl Blumenauer (D-OR) speaking at a NORML Conference On Wednesday, October 11th, Congressional Cannabis Caucus Co-Chair Earl Blumenauer (D-OR) testified before the House Energy & Commerce Subcommittee on Health on how to deal with the opioid crisis in America. In his testimony, the Congressman makes the case for medical cannabis as a safer alternative … Continue reading
Study: Patients Report Substituting Cannabis For Opioids, Other Pain Medications
Pain patients report successfully substituting cannabis for opioids and other analgesics, according to data published online in the journal Cannabis and Cannabinoid Research. Researchers from the University of California, Berkeley and Kent State University in Ohio assessed survey data from a cohort of 2,897 self-identified medical cannabis patients. Among those who acknowledged having used opioid-based … Continue reading
Medical Marijuana as an Alternative to Opioids
This Friday, June 16, the Office of National Drug Control Policy will convene it’s first meeting of President Trump’s “Commission on Combating Drug Addiction and the Opioid Crisis.” The Commission is tasked with making recommendations for improving the Federal response to opioid misuse and abuse. Best evidence informs us that medical marijuana access is associated … Continue reading
Jeff Sessions: Wrong on Opioids and Violence, Considers RICO Lawsuits
Attorney General Jeff SessionsPhoto by Gage Skidmore Attorney General Jeff Sessions appeared with conservative talk radio host Hugh Hewitt to discuss a range of issues, including how the Trump administration intends to address marijuana law enforcement in states that are regulating its adult use. During the interview, Hewitt repeatedly encourages Sessions to engage in federal … Continue reading
Study: Medical Cannabis Use Associated With Improved Cognitive Performance, Reduced Use Of Opioids
Medical cannabis administration is associated with improved cognitive performance and lower levels of prescription drug use, according to longitudinal data published online in the journal Frontiers in Pharmacology. Investigators from Harvard Medical School, Tufts University, and McLean Hospital evaluated the use of medicinal cannabis on patients’ cognitive performance over a three-month period. Participants in the … Continue reading
